Purpose This study aimed to assess the incidence of and factors associated with major
complications, delayed discharge, and emergency room (ER) visits or readmission after …

AIM: To evaluate outcomes of radiofrequency ablation (RFA) therapy for early hepatocellular
carcinoma (HCC) and identify survival-and recurrence-related factors. METHODS …

Resection and radiofrequency ablation (RFA) are treatment options for hepatocellular
carcinoma (HCC)< 3 cm; there is interest in expanding the role of ablation to 3‐5 cm. RFA is …

AIM: To evaluate survival and recurrence after radiofrequency ablation (RFA) for the
treatment of small hepatocellular carcinoma (HCC) using a meta-analysis. METHODS …

Radiofrequency ablation (RFA) as a local therapy for liver cancer is widely used. The study
is to evaluate the therapeutic efficacy of RFA on hepatocellular carcinoma (HCC) and …

Objective To determine the efficacy of radiofrequency ablation (RFA) for initial recurrence of
small hepatocellular carcinoma (HCC;≤ 3 nodules, each nodule≤ 3 cm in diameter) after …

Background We aim to investigate the safety and efficacy of radiofrequency ablation in the
treatment of solitary hepatocellular carcinoma (3–5 cm) in comparison with surgical …

Objectives To compare the efficacy of transarterial chemoembolization (TACE) and
radiofrequency ablation (RFA) for patients with single small (≤ 3 cm) hepatocellular …

Abstract Background and Aim Radiofrequency ablation (RFA) and percutaneous ethanol
injection (PEI) have been used for patients with hepatocellular carcinomas (HCCs)< 3 cm …

Background & Aims The therapeutic outcomes of surgical resection (SR) or radiofrequency
ablation (RFA) for perivascular hepatocellular carcinoma (HCC) have not been compared …